Mesoblast (MESO) Change in Account Payables (2016 - 2023)
Mesoblast (MESO) reported Change in Account Payables of -$2.0 million for Q1 2023, down 40.36% on a YoY basis from -$3.4 million in Q1 2022, and down 140.09% sequentially from $5.0 million in Q4 2022.
Mesoblast (MESO) Change in Account Payables (2016 - 2023) Analysis & Trends
Mesoblast (MESO) has 8 years of Change in Account Payables data on file, last reported at -$2.0 million in Q1 2023.
- For the quarter ending Q1 2023, Change in Account Payables fell 40.36% year-over-year to -$2.0 million; the trailing twelve-month figure through Mar 2023 stood at $4.7 million (up 1581.36% YoY), and the FY2022 full-year result was $4.8 million, up 194.39% from the prior year.
- Change in Account Payables declined to -$2.0 million in Q1 2023, from $5.0 million in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $6.2 million in Q4 2019 to a low of -$3.0 million in Q3 2021.
- A 5-year average of $1.3 million and a median of -$300000.0 in 2019 frame the typical range for Change in Account Payables.
- Peak annual rise in Change in Account Payables reached 1346.12% in 2021, while the deepest fall reached 183.75% in 2021.
- Tracing MESO's Change in Account Payables over 5 years: stood at $6.2 million in 2019, then tumbled by 106.63% to -$412000.0 in 2020, then surged by 1346.12% to $5.1 million in 2021, then decreased by 2.69% to $5.0 million in 2022, then sank by 140.09% to -$2.0 million in 2023.
- Business Quant data shows MESO's Change in Account Payables at -$2.0 million in Q1 2023, $5.0 million in Q4 2022, and -$2.4 million in Q3 2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | -42.19 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 35.60 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 16.86 Mn |
| 10 | Mesoblast | 19.81 Bn | 19.68 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | -2.00 Mn |
| Mar 31, 2023 | -2.00 Mn |
| Dec 31, 2022 | 5.00 Mn |
| Dec 31, 2022 | 5.00 Mn |
| Sep 30, 2022 | -2.39 Mn |
| Sep 30, 2022 | -2.39 Mn |
| Jun 30, 2022 | 4.09 Mn |
| Jun 30, 2022 | 4.09 Mn |
| Mar 31, 2022 | -1.43 Mn |
| Mar 31, 2022 | -1.43 Mn |
| Dec 31, 2021 | 5.13 Mn |
| Dec 31, 2021 | 5.13 Mn |
| Sep 30, 2021 | -3.02 Mn |
| Sep 30, 2021 | -3.02 Mn |
| Dec 31, 2020 | -412,000.00 |
| Dec 31, 2020 | -412,000.00 |
| Sep 30, 2020 | 3.60 Mn |
| Sep 30, 2020 | 3.60 Mn |
| Dec 31, 2019 | 6.21 Mn |
| Dec 31, 2019 | 6.21 Mn |